{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "TDOC",
  "name": "Teladoc Health, Inc.",
  "url": "https://frontierpicks.com/dossiers/TDOC/",
  "json_url": "https://frontierpicks.com/dossiers/TDOC.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "The Walmart/insurance-pivot re-rating broke at the 2026-07-29 Q2 print: revenue -4% YoY, BetterHelp -12%, FY26 revenue guide cut ~5% at the midpoint. What remains is $774M cash and a maintained $130-170M FCF guide against a shrinking top line — and nothing dated resolves the in-network transition before the ~late-October Q3 print.",
  "invalidation_trigger": "A weekly close below $6.00 round-trips the entire Walmart-deal re-rating and returns price to the $4.40-$6 zone; a Q3 print (~late October) with BetterHelp paying users under Q2's 0.346M plus another FY revenue guide cut would confirm the in-network transition is not stabilizing.",
  "catalyst_date": null,
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "managed-care-health-services",
    "precision-biotech-therapeutics"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Teladoc reports two segments with divergent trends — Integrated Care (+1% YoY in Q2 2026) and BetterHelp (-12%); consolidated revenue averages two different demand exposures.",
    "BetterHelp is mid-transition from cash-pay to in-network reimbursement, so paying-user counts mix two revenue models and are not clean sequential comparables.",
    "FY2026 free-cash-flow guidance of $130-170M was maintained on 2026-07-29 while revenue guidance was cut, so cash conversion and revenue trend can move in opposite directions.",
    "Q3 2026 reporting date is not yet confirmed; prior-year cadence puts it in late October, outside any 30-day window from mid-August."
  ],
  "body_markdown": "## Current Thesis\nThe turnaround leg this note tracked from July has failed its own gate. The 2026-07-29 Q2 print was the binary, and it printed on the bear side of every watch item: total revenue $606.9M (-4% YoY), BetterHelp revenue $212.6M (-12% YoY), average paying users 0.346M against Q1's 0.361M, and a full-year revenue guide cut roughly 5% at the midpoint to $2,362-2,447M from the $2,480-2,580M reaffirmed on 2026-04-29. The $8.00 weekly-close level flagged as the post-Walmart-deal shelf gave way; the 2026-08-14 close of $6.81 sits 29.9% under the $9.72 52-week high. What an investor is left underwriting is narrower and less exciting than the July story: a company with $774.3M of cash at 2026-06-30, an unchanged $130-170M free-cash-flow guide, and a mental-health segment mid-way through swapping a shrinking cash-pay book for an in-network one whose economics are not yet visible in the P&L. That is a balance-sheet-and-transition argument, not a re-rating.\n\n## Bull Case\n- Adjusted EBITDA guidance was reset to $271-303M, a range whose midpoint is close to the prior $267-306M.\n- **The demand problem is capacity, per management.** On the 2026-07-29 release the CEO said insurance demand outpaced provider capacity and that the company \"accelerated the nationwide insurance rollout ahead of plan.\" If that framing holds, the BetterHelp decline is a supply-side transition cost with a defined end, not terminal churn.\n- **Integrated Care is still growing and adding covered lives.** Segment revenue was $394.3M in Q2 (+1% YoY) with a 16.5% adjusted EBITDA margin; U.S. members reached 100.3M at 2026-06-30; chronic-care enrollment was 1.272M, +14% YoY. The larger half of the business is compounding enrollment even while the consumer half contracts.\n- **Sell-side targets now sit above the tape rather than below it.** Citi cut to $7.50 on 2026-08-03 (from $11), Evercore ISI to $7.50 on 2026-07-30 (from $10), Jefferies to $8 on 2026-07-30 (from $9). In July the stock traded above nearly every target; at $6.81 it trades under those three marks. Stockanalysis.com shows a 17-analyst average of $7.56 with a $5-$11 range as of mid-August 2026.\n- **Momentum is washed out on the short-term oscillator.** RSI(14) was 29.7 at the 2026-08-14 close, the first oversold reading of this leg.\n\n## Bear Case\n- **Every segment line moved the wrong way in Q2.** Revenue -4% YoY vs -2% in Q1; net loss $38.9M (-$0.21/sh); adjusted EBITDA $65.7M, -5% YoY. BetterHelp's adjusted EBITDA margin was 0.2% — the segment contributed effectively nothing at the profit line in the quarter.\n- **The guidance cut was specific and recent.** BetterHelp FY2026 revenue was taken to $770-830M from $810-870M, with management citing cash-pay pressure that \"accelerated further in late May and into June, beyond our prior assumptions.\" That timing means the deterioration was already running while the stock made its July high.\n- **Q3 guidance implies no immediate inflection.** Revenue $569-609M and adjusted EBITDA $62-74M for Q3 both bracket levels below the Q2 actuals of $606.9M and $65.7M at the midpoint.\n- **The Walmart channel did not appear as a quantified driver.** The Better Care Services distribution deal (~2026-05-28) that carried the stock 15.8% higher in a session was not accompanied by disclosed ramp metrics in the Q2 release. The catalyst that created the leg has so far produced no reported number.\n- **Structure is broken, and the prior break level is now overhead.** The $8.00 shelf that defined the post-deal base is above the market; a stock that loses its breakout base after a guidance cut typically needs a new sponsor, and none is dated.\n\n## Setup & Price Structure\n- 2026-08-14 close $6.81; 52-week high $9.72; drawdown -29.9%. Three-month return is still +7.1%, meaning the entire remaining gain belongs to the May-July leg and the post-print decline has retraced most of it.\n- The $8.00 weekly-close level named as the invalidation in the prior note broke after 2026-07-29. That level is now resistance rather than support, and reclaiming it on a weekly close is the cleanest evidence that the transition story is being re-underwritten.\n- Downside reference is the $4.40 52-week low. Between $6.81 and that low there is no dated shelf from this cycle other than the pre-Walmart-deal zone the stock occupied before ~2026-05-28.\n- Positioning observables: three price-target cuts inside six sessions (2026-07-30 Jefferies and Evercore ISI, 2026-08-03 Citi), all landing at or below $8; RSI(14) 29.7; no earnings date inside the next 30 days, so the calendar offers no scheduled forcing event to compress the range.\n- The narrative is **dead** for the leg as constructed. The narrative that priced from ~2026-05-28 (Walmart distribution) through the 2026-07-08 renewed-attention coverage and the July high failed its verification event on 2026-07-29 and lost the structure that defined it. A different, slower argument — in-network BetterHelp reaching scale — may build later, but it has no dated evidence yet and no confirmed base.\n\n## Catalyst Calendar (next 30 days)\n\n- **No confirmed company catalyst between 2026-08-15 and 2026-09-14.** Q2 results were released 2026-07-29 and the Q3 report has not been scheduled as of this writing; on prior-year cadence it lands in late October (~2026-10-28, est.).\n- **~2026-10-28 (est.) — Q3 2026 results.** First checkpoint against the Q3 guide of $569-609M revenue / $62-74M adjusted EBITDA, and the first read on whether BetterHelp paying users stabilize versus Q2's 0.346M.\n\n## Elapsed catalysts\n\n- **Ongoing, undated — nationwide BetterHelp in-network rollout.** Management said on 2026-07-29 it was accelerated ahead of plan; any interim disclosure of covered-lives or in-network visit volume would arrive outside the earnings calendar. *(passed 28d ago)*\n- **Ongoing, undated — analyst revisions.** The cluster of cuts on 2026-07-30 and 2026-08-03 reset the target range; further moves would come without a fixed date. *(passed 23d ago)*\n\n## What Would Change Our Mind\nThe structure that defined the bull leg is already gone — the $8.00 shelf broke after the 2026-07-29 print and the FY revenue guide was cut, so the July thesis has been settled against, not left pending. What would rebuild a case is narrow and checkable: a weekly close back above $8.00 that reclaims the broken shelf, or a Q3 report (~late October) showing BetterHelp paying users at or above 0.346M with the FY revenue range held at $2,362-2,447M rather than cut again. Evidence that in-network revenue is replacing cash-pay dollars — a disclosed in-network revenue figure, or BetterHelp segment adjusted EBITDA margin back toward the 3.0-4.6% full-year band from Q2's 0.2% — would matter more than any single revenue line. On the downside, a weekly close below $6.00 round-trips the entire Walmart-deal re-rating and puts the stock back into the $4.40-$6 zone it occupied before 2026-05-28; a second consecutive FY guidance cut at the Q3 print would confirm that the transition is destroying more revenue than it is converting.\n\n## Correlation Notes\n- The drawdown dates to the 2026-07-29 print and the guidance cut, not to a sector-wide event; readers separating company-specific damage from sector beta can compare the same 2026-07-29-to-2026-08-14 window against other consumer-telehealth and virtual-care names before attributing the move.\n- The two segments do not correlate with the same things. Integrated Care (100.3M U.S. members, 1.272M chronic-care enrollees at 2026-06-30) tracks employer and health-plan benefit budgets and renewal cycles; BetterHelp tracks consumer discretionary spending and, increasingly, behavioural-health reimbursement policy. Consolidated revenue averages two different exposures.\n- With a $774.3M cash position and a maintained $130-170M FCF guide against a mid-single-digit-dollar share price, the equity behaves partly as a balance-sheet story, which links it to small-cap unprofitable-healthcare risk appetite rather than to managed-care fundamentals.\n- Reimbursement headlines for behavioural health — payer coverage decisions, telehealth parity rules — are now a direct input to the BetterHelp line in a way they were not under the cash-pay model.",
  "first_seen": "2026-07-14",
  "last_analyzed": "2026-08-15T09:26:42+00:00",
  "last_synthesized": "2026-08-15",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}